Literature DB >> 17180163

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms.

Michelle L Block1, Luigi Zecca, Jau-Shyong Hong.   

Abstract

Mounting evidence indicates that microglial activation contributes to neuronal damage in neurodegenerative diseases. Recent studies show that in response to certain environmental toxins and endogenous proteins, microglia can enter an overactivated state and release reactive oxygen species (ROS) that cause neurotoxicity. Pattern recognition receptors expressed on the microglial surface seem to be one of the primary, common pathways by which diverse toxin signals are transduced into ROS production. Overactivated microglia can be detected using imaging techniques and therefore this knowledge offers an opportunity not only for early diagnosis but, importantly, for the development of targeted anti-inflammatory therapies that might slow or halt the progression of neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17180163     DOI: 10.1038/nrn2038

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  1505 in total

1.  Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson's disease.

Authors:  Souvarish Sarkar; Hai M Nguyen; Emir Malovic; Jie Luo; Monica Langley; Bharathi N Palanisamy; Neeraj Singh; Sireesha Manne; Matthew Neal; Michelle Gabrielle; Ahmed Abdalla; Poojya Anantharam; Dharmin Rokad; Nikhil Panicker; Vikrant Singh; Muhammet Ay; Adhithiya Charli; Dilshan Harischandra; Lee-Way Jin; Huajun Jin; Srikant Rangaraju; Vellareddy Anantharam; Heike Wulff; Anumantha G Kanthasamy
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

2.  Naturally occurring genetic variability in expression of Gsta4 is associated with differential survival of axotomized rat motoneurons.

Authors:  Mikael Ström; Faiez Al Nimer; Rickard Lindblom; Jens Randel Nyengaard; Fredrik Piehl
Journal:  Neuromolecular Med       Date:  2011-12-08       Impact factor: 3.843

3.  Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.

Authors:  Nadia Stefanova; Biljana Georgievska; Håkan Eriksson; Werner Poewe; Gregor K Wenning
Journal:  Neurotox Res       Date:  2011-12-08       Impact factor: 3.911

Review 4.  Misfolded α-synuclein and Toll-like receptors: therapeutic targets for Parkinson's disease.

Authors:  Dawn Béraud; Kathleen A Maguire-Zeiss
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

5.  Inhibition of the cluster of differentiation 14 innate immunity pathway with IAXO-101 improves chronic microelectrode performance.

Authors:  John K Hermann; Madhumitha Ravikumar; Andrew J Shoffstall; Evon S Ereifej; Kyle M Kovach; Jeremy Chang; Arielle Soffer; Chun Wong; Vishnupriya Srivastava; Patrick Smith; Grace Protasiewicz; Jingle Jiang; Stephen M Selkirk; Robert H Miller; Steven Sidik; Nicholas P Ziats; Dawn M Taylor; Jeffrey R Capadona
Journal:  J Neural Eng       Date:  2018-04       Impact factor: 5.379

Review 6.  Microglial voltage-gated proton channel Hv1 in ischemic stroke.

Authors:  Long-Jun Wu
Journal:  Transl Stroke Res       Date:  2013-10-03       Impact factor: 6.829

7.  Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination.

Authors:  Andrew V Caprariello; Saisho Mangla; Robert H Miller; Stephen M Selkirk
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

8.  Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells.

Authors:  Wei-Ching Huang; Yee-Shin Lin; Chi-Yun Wang; Cheng-Chieh Tsai; Hsiang-Chi Tseng; Chia-Ling Chen; Pei-Jung Lu; Po-See Chen; Li Qian; Jau-Shyong Hong; Chiou-Feng Lin
Journal:  Immunology       Date:  2008-10-29       Impact factor: 7.397

9.  A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist.

Authors:  Natasha T Snider; James A Nast; Laura A Tesmer; Paul F Hollenberg
Journal:  Mol Pharmacol       Date:  2009-01-26       Impact factor: 4.436

10.  Effective neuroprotection by ischemic postconditioning is associated with a decreased expression of RGMa and inflammation mediators in ischemic rats.

Authors:  Yuhan Kong; Mary R Rogers; Xinyue Qin
Journal:  Neurochem Res       Date:  2013-02-07       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.